Doležalová, Pavla
,
Bohm, Marek
Linková, Lenka
Saifrídová, Melánia
Němcová, Dana
Dallos, Tomáš
Consolaro, Alessandro
Bovis, Francesca
Ruperto, Nicolino
Article History
Received: 22 December 2017
Accepted: 11 January 2018
First Online: 7 April 2018
Compliance with ethical standards
:
: Dr. Bohm, Dr. Saifrídová, Dr. Němcová, Dr. Linková and Dr. Doležalová received Grant no. IGA MZ ČR NT 14149-3/2013 and funding support from Istituto Giannina Gaslini, Genoa, Italy, for the translation phase and data collection performed at their site, within the EPOCA project. Dr. Doležalová reports also personal fees and non-financial support from Pfizer, Abbvie, Roche, MEDAC, personal fees from Novartis, non-financial support from SOBI outside the submitted work. Dr. Ruperto has received Grants from BMS, Hoffman-La Roche, Janssen, Novartis, Pfizer, Sobi, during the conduct of the study and personal fees and speaker honorarium from Abbvie, Ablynx, Amgen, AstraZeneca, Baxalta Biosimilars, Biogen Idec, Boehringer, Bristol Myers Squibb, Celgene, Eli-Lilly, EMD Serono, Gilead Sciences, Janssen, Medimmune, Novartis, Pfizer, Rpharm, Roche, Sanofi, Servier and Takeda. Dr. Consolaro, Dr. Bovis and Dr. Dallos have nothing to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study as per the requirement of the local ethical committee.